NAOVNanoVibronix, Inc.

Nasdaq nanovibronix.com


$ 0.76 $ 0.01 (1.13 %)    

Monday, 22-Apr-2024 15:56:08 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.758499
$ 0.75
$ 0.00 x 0
$ 0.00 x 0
$ 0.75 - $ 0.76
$ 0.70 - $ 4.34
15,302
na
1.33M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-08-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 04-17-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 04-14-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-24-2021 03-31-2021 10-Q
13 04-15-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-19-2020 06-30-2020 10-Q
16 07-06-2020 03-31-2020 10-Q
17 05-20-2020 12-31-2019 10-K
18 11-19-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-20-2019 03-31-2019 10-Q
21 04-15-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-29-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-16-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 03-30-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nanovibronix-issues-letter-to-stockholders

We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, whi...

 nanovibronix-signs-agreement-for-research-and-development-of-next-generation-painshield-and-uroshield

Efforts Focused on Adding Therapeutic Functionality and Reducing CostsNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" ...

 nanovibronix-shares-resume-trade
NanoVibronix Shares Resume Trade
01/25/2024 16:14:12

 nanovibronix-announces-agreement-for-clinical-study-of-uroshield-at-the-university-of-michigan

Gathering Additional Clinical Evidence to Support Application to FDA for Permanent ClearanceNanoVibronix, Inc. (NASDAQ:NAOV), a...

 nanovibronix-regains-nasdaq-compliance

NanoVibronix, Inc., (NASDAQ:NAOV) (the "Company"), a medical device company that produces the UroShield® and PainShield...

 nanovibronix-uroshield-products-available-on-nhs-drug-tariff-effective-november-1

Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing DemandNanoVibronix, Inc. (Nasdaq: NAOV), a...

 why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

 nanovibronix-announces-presentation-of-independent-testing-results-of-uroshield-at-ics-annual-meeting

Dr. Sandra Wilks to Present Findings from University of Southampton Study in Toronto NanoVibronix, Inc., (NASDAQ:NAOV), a medi...

 why-rex-american-resources-are-trading-lower-by-9-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 89.5% to $2.7852 after the company reported outcomes from a UroShiel...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION